Log in

NASDAQ:DOX - Amdocs Stock Price, Forecast & News

-1.88 (-2.76 %)
(As of 02/28/2020 01:43 AM ET)
Today's Range
Now: $66.19
50-Day Range
MA: $73.16
52-Week Range
Now: $66.19
Volume1.59 million shs
Average Volume856,433 shs
Market Capitalization$8.92 billion
P/E Ratio18.34
Dividend Yield1.67%
Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company offers amdocsONE a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support, as well as consumer experience and monetization, media and digital, enterprise and connected society, service-driven network, and services and agile operation solutions. Read More…

Industry, Sector and Symbol

Industry Custom computer programming services
Sub-IndustryIT Consulting & Other Services
SectorComputer and Technology
Current SymbolNASDAQ:DOX
Phone1 314 212 7000



Sales & Book Value

Annual Sales$4.09 billion
Cash Flow$5.48 per share
Book Value$26.58 per share


Net Income$479.45 million


Market Cap$8.92 billion
Next Earnings Date5/12/2020 (Estimated)

Receive DOX News and Ratings via Email

Sign-up to receive the latest news and ratings for DOX and its competitors with MarketBeat's FREE daily newsletter.

Amdocs (NASDAQ:DOX) Frequently Asked Questions

What is Amdocs' stock symbol?

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

How often does Amdocs pay dividends? What is the dividend yield for Amdocs?

Amdocs declared a quarterly dividend on Tuesday, February 4th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.327 per share on Friday, April 24th. This represents a $1.31 annualized dividend and a yield of 1.98%. The ex-dividend date is Monday, March 30th. This is a boost from Amdocs's previous quarterly dividend of $0.29. View Amdocs' Dividend History.

How were Amdocs' earnings last quarter?

Amdocs Limited (NASDAQ:DOX) released its quarterly earnings data on Tuesday, February, 4th. The technology company reported $1.06 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.05 by $0.01. The technology company had revenue of $1.04 billion for the quarter, compared to the consensus estimate of $1.03 billion. Amdocs had a return on equity of 16.13% and a net margin of 11.99%. Amdocs's revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.98 EPS. View Amdocs' Earnings History.

When is Amdocs' next earnings date?

Amdocs is scheduled to release their next quarterly earnings announcement on Tuesday, May 12th 2020. View Earnings Estimates for Amdocs.

What guidance has Amdocs issued on next quarter's earnings?

Amdocs updated its FY20 earnings guidance on Tuesday, February, 4th. The company provided earnings per share (EPS) guidance of $4.44-4.61 for the period, compared to the Thomson Reuters consensus estimate of $4.52. The company issued revenue guidance of $4.19-4.31 billion, compared to the consensus revenue estimate of $4.22 billion.

What price target have analysts set for DOX?

5 brokers have issued 12 month price objectives for Amdocs' shares. Their forecasts range from $72.00 to $85.00. On average, they expect Amdocs' share price to reach $77.80 in the next twelve months. This suggests a possible upside of 17.5% from the stock's current price. View Analyst Price Targets for Amdocs.

What is the consensus analysts' recommendation for Amdocs?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Amdocs.

Has Amdocs been receiving favorable news coverage?

Press coverage about DOX stock has been trending very negative this week, according to InfoTrie. The research firm rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Amdocs earned a coverage optimism score of -3.2 on InfoTrie's scale. They also gave news stories about the technology company a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next several days. View News Stories for Amdocs.

Are investors shorting Amdocs?

Amdocs saw a increase in short interest during the month of February. As of February 14th, there was short interest totalling 3,690,000 shares, an increase of 9.8% from the January 30th total of 3,360,000 shares. Based on an average daily volume of 776,500 shares, the short-interest ratio is currently 4.8 days. Currently, 2.7% of the company's shares are short sold. View Amdocs' Current Options Chain.

Who are some of Amdocs' key competitors?

What other stocks do shareholders of Amdocs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include AbbVie (ABBV), Home Depot (HD), AT&T (T), QUALCOMM (QCOM), Enterprise Products Partners (EPD), Activision Blizzard (ATVI), Comcast (CMCSA), Intel (INTC), Boeing (BA) and Caterpillar (CAT).

Who are Amdocs' key executives?

Amdocs' management team includes the folowing people:
  • Mr. Joshua Sheffer, Pres & CEO (Age 59)
  • Ms. Tamar Rapaport-Dagim, CFO & COO (Age 48)
  • Mr. Matthew E. Smith, Sec. & Head of Investor Relations (Age 47)
  • Mr. Gary Miles, Chief Marketing Officer
  • Darcy Antonellis, Head of Amdocs Media

Who are Amdocs' major shareholders?

Amdocs' stock is owned by many different of institutional and retail investors. Top institutional investors include FMR LLC (11.85%), Janus Henderson Group PLC (5.60%), Massachusetts Financial Services Co. MA (3.11%), LSV Asset Management (2.56%), Beutel Goodman & Co Ltd. (2.14%) and AQR Capital Management LLC (2.00%).

Which institutional investors are selling Amdocs stock?

DOX stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Echo Street Capital Management LLC, Alliancebernstein L.P., Barclays PLC, Goldman Sachs Group Inc., Janus Henderson Group PLC, PGGM Investments and Eaton Vance Management.

Which institutional investors are buying Amdocs stock?

DOX stock was acquired by a variety of institutional investors in the last quarter, including Bessemer Group Inc., Schroder Investment Management Group, Acadian Asset Management LLC, AJO LP, Stifel Financial Corp, Anchor Capital Advisors LLC, Citigroup Inc. and Charles Schwab Investment Management Inc..

How do I buy shares of Amdocs?

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Amdocs' stock price today?

One share of DOX stock can currently be purchased for approximately $66.19.

How big of a company is Amdocs?

Amdocs has a market capitalization of $8.92 billion and generates $4.09 billion in revenue each year. The technology company earns $479.45 million in net income (profit) each year or $4.07 on an earnings per share basis. Amdocs employs 24,516 workers across the globe.View Additional Information About Amdocs.

What is Amdocs' official website?

The official website for Amdocs is http://www.amdocs.com/.

How can I contact Amdocs?

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]

MarketBeat Community Rating for Amdocs (NASDAQ DOX)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  602 (Vote Outperform)
Underperform Votes:  450 (Vote Underperform)
Total Votes:  1,052
MarketBeat's community ratings are surveys of what our community members think about Amdocs and other stocks. Vote "Outperform" if you believe DOX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DOX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/28/2020 by MarketBeat.com Staff

Featured Article: What are no-load funds?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel